Cullinan Therapeutics, Inc. (CGEM)

NASDAQ: CGEM · Real-Time Price · USD

12.23

+0.38 (3.21%)

At close: Feb 6, 2026, 4:00 PM EST

12.47

+0.24 (1.96%)

After-hours: Feb 6, 2026, 7:07 PM EST

Cullinan Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 6, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	723	709	436	483	674	-
Market Cap Growth	17.50%	62.69%	-9.73%	-28.36%	-	-
Enterprise Value	391	134	-25	-88	355	-
Last Close Price	12.23	12.18	10.19	10.55	15.43	-
PE Ratio	-	-	-	4.34	-	-
PS Ratio	-	-	-	-	35.58	-
PB Ratio	1.60	1.20	0.96	0.90	1.59	-
P/TBV Ratio	1.60	1.20	0.96	0.90	1.59	-
EV/Sales Ratio	-	-	-	-	18.75	-
Debt / Equity Ratio	0.00	0.00	0.01	0.01	-	-
Asset Turnover	-	-	-	-	0.06	-
Quick Ratio	10.15	13.23	16.60	20.77	24.73	14.68
Current Ratio	10.45	13.53	17.07	21.09	25.25	14.82
Return on Equity (ROE)	-40.18%	-32.10%	-31.37%	22.74%	-21.57%	-39.88%
Return on Assets (ROA)	-26.53%	-22.26%	-22.80%	-16.55%	-13.03%	-23.93%
Return on Invested Capital (ROIC)	-138.70%	-214.14%	-601.95%	-89.53%	-108.71%	-
Return on Capital Employed (ROCE)	-53.50%	-33.30%	-41.80%	-24.50%	-16.00%	-30.10%
Earnings Yield	-30.01%	-23.60%	-35.13%	23.03%	-9.73%	-
FCF Yield	-24.13%	-20.49%	-30.85%	-26.46%	-6.44%	-
Buyback Yield / Dilution	-18.23%	-29.41%	10.91%	-8.27%	-116.61%	-2088.17%

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q